China Shineway Pharmaceutical Group Limited
CSWYYOTCHealthcare● Active
$19.25
+$0.00(+0.00%)
Market Cap$36353625
P/E Ratio—
52W High$22.54
52W Low$19.25
China Shineway Pharmaceutical Group Limited (CSWYY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CSWYY · earnings · updated Jun 10, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 26, 2026EPS Actual
$24.99
Revenue
$0.21B
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 26, 2026
After Market Close
CSWYY reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Next earnings date not yet announced.
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q1 FY2026 | Mar 26, 2026 | — | $24.99 | — | $0.21B | — | — |
| ◌ Q3 FY2025 | Sep 1, 2025 | — | — | — | — | — | — |
| ◌ Q1 FY2025 | Mar 26, 2025 | — | — | — | — | — | — |
| ◌ Q3 FY2024 | Aug 29, 2024 | — | — | — | — | $0.80B | — |
| ◌ Q1 FY2024 | Mar 28, 2024 | — | — | — | — | — | — |
| — Q4 FY2023 | Dec 31, 2023 | — | $35.74 | — | $0.30B | — | — |
| — Q2 FY2023 | Jun 30, 2023 | — | $35.92 | — | $0.33B | — | — |
| — Q4 FY2022 | Dec 31, 2022 | — | $30.29 | — | $0.31B | — | — |
Q1 FY2026
Mar 26, 2026
EPS Actual
$24.99
EPS Est.
—
EPS Surpr.
—
Revenue
$0.21B
Q3 FY2025
Sep 1, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 26, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 29, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 28, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Dec 31, 2023
EPS Actual
$35.74
EPS Est.
—
EPS Surpr.
—
Revenue
$0.30B
Q2 FY2023
Jun 30, 2023
EPS Actual
$35.92
EPS Est.
—
EPS Surpr.
—
Revenue
$0.33B
Q4 FY2022
Dec 31, 2022
EPS Actual
$30.29
EPS Est.
—
EPS Surpr.
—
Revenue
$0.31B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2024 | $5.9B | $5.9B | $5.9B | 1 |
| Q3 FY2024 | $5.6B | $5.6B | $5.6B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Mar 26, 2026 | — | $19.25 | $19.25 | +0.00% |
| — Q4 FY2023 | Dec 31, 2023 | — | $18.80 | $18.80 | +0.00% |
| — Q2 FY2023 | Jun 30, 2023 | — | $18.80 | $18.80 | +0.00% |
| — Q4 FY2022 | Dec 31, 2022 | — | $12.12 | $12.12 | +0.00% |
| — Q2 FY2022 | Jun 30, 2022 | — | $22.13 | $22.13 | +0.00% |
| — Q4 FY2021 | Dec 31, 2021 | — | $22.13 | $22.13 | +0.00% |
| — Q2 FY2021 | Jun 30, 2021 | — | $22.13 | $22.13 | +0.00% |
| — Q4 FY2020 | Dec 31, 2020 | — | $22.13 | $22.13 | +0.00% |
Q1 FY2026+0.00%
Report Date
Mar 26, 2026
EPS Beat/Miss
—
Price Before
$19.25
Price After
$19.25
Q4 FY2023+0.00%
Report Date
Dec 31, 2023
EPS Beat/Miss
—
Price Before
$18.80
Price After
$18.80
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$18.80
Price After
$18.80
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$12.12
Price After
$12.12
Q2 FY2022+0.00%
Report Date
Jun 30, 2022
EPS Beat/Miss
—
Price Before
$22.13
Price After
$22.13
Q4 FY2021+0.00%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$22.13
Price After
$22.13
Q2 FY2021+0.00%
Report Date
Jun 30, 2021
EPS Beat/Miss
—
Price Before
$22.13
Price After
$22.13
Q4 FY2020+0.00%
Report Date
Dec 31, 2020
EPS Beat/Miss
—
Price Before
$22.13
Price After
$22.13
Beat Rate0 / 8 quarters
Largest Move+0.00% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CSWYY ends December
China Shineway Pharmaceutical Group Limited (CSWYY) most recently reported earnings on March 26, 2026 for Q1 FY2026, posting EPS of $24.99 (in line with the analyst consensus of —).
Each quarter, investors track CSWYY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CSWYY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CSWYY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CSWYY earnings · 4 questionsChina Shineway Pharmaceutical Group Limited's next earnings report is expected around TBD. CSWYY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CSWYY historically reports after market close (AMC).
CSWYY earnings datewhen is CSWYY earningsCSWYY next earnings datewhen does CSWYY report earningsCSWYY earnings calendar
▸ Source: FMP · China Shineway Pharmaceutical Group Limited SEC filings · US GAAP · China Shineway Pharmaceutical Group Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026